查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1813814

全球小分子创新 CDMO 市场：市场规模、份额和趋势分析（按产品、阶段类型、治疗领域、客户类型和地区）、按细分市场预测（2025-2033 年）

Small Molecule Innovator CDMO Market Share & Trends Analysis Report By Product (Small Molecule API, Small Molecule Drug Product), By Stage Type (Clinical, Commercial), By Therapeutic Area, By Customer Type, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 145 Pages | 商品交期: 2-10个工作天内

价格

小分子创新CDMO市场摘要

预计 2024 年全球小分子创新 CDMO 市场价值将达到 413.9 亿美元，到 2033 年将达到 693.8 亿美元，2025 年至 2033 年的复合年增长率为 6.07%。

新兴市场的成长是由越来越多的製药公司将药物开发和製造外包所推动的，特别是在小分子领域。

随着药物管道变得越来越复杂以及监管审查的加强，製药公司越来越依赖 CDMO 来提供专业服务，例如原料药合成、製剂开发和临床规模生产。製药公司越来越依赖外包，因为他们寻求简化营运、减少内部製造负担并缩短药物开发时间，这推动了市场的发展。创新者，尤其是基础设施有限的新兴生物技术公司，越来越多地转向 CDMO 寻求从早期开发到商业製造的专业服务。监管合规的复杂性、对高活性原料药的先进遏制设施的需求以及维持内部能力的高成本强化了这一趋势。针对癌症、感染疾病和罕见疾病的临床试验和新分子实体 (NME) 的兴起正在推动对在 cGMP 条件下提供高品质原料药製造、分析测试和製剂开发专业知识的 CDMO 的需求。

目录

第一章 分析方法与范围

第二章执行摘要

3. 小分子创新 CDMO 市场：驱动因素、趋势与范围

  • 市场联动展望
  • 小分子创新者 CDMO 市场动态
  • 技术格局
  • 定价模式分析
  • 小分子创新者 CDMO 市场：分析工具

第四章 小分子创新 CDMO 市场：依产品的估计与趋势分析

  • 细分仪表板
  • 全球小分子创新 CDMO 市场：按产品分類的变化分析
  • 全球小分子创新 CDMO 市场规模与趋势分析（按产品）（2021-2033 年）
  • 小分子API
  • 小分子药物
    • 口服固态剂型
    • 半固态
    • 液体剂型
    • 其他的

第五章 小分子创新 CDMO 市场：依阶段类型估计与趋势分析

  • 细分仪表板
  • 全球小分子创新 CDMO 市场：以阶段类型变化分析
  • 全球小分子创新 CDMO 市场规模与趋势分析（按阶段类型）（2021-2033 年）
  • 临床前
  • 临床
    • 第一阶段
    • 第二阶段
    • 第三阶段
  • 上市

6. 小分子创新 CDMO 市场：按客户类型进行的估计和趋势分析

  • 细分仪表板
  • 全球小分子创新 CDMO 市场：依客户类型进行趋势分析
  • 全球小分子创新 CDMO 市场规模与趋势分析（按客户类型）（2021-2033 年）
  • 製药
    • 小型企业
    • 中型公司
    • 大公司
  • 生物技术

7. 小分子创新 CDMO 市场：依治疗领域的估计与趋势分析

  • 细分仪表板
  • 全球小分子创新 CDMO 市场：依治疗领域变化分析
  • 全球小分子创新 CDMO 市场规模及趋势分析（依治疗领域）（2021-2033 年）
  • 心血管疾病
  • 肿瘤学
  • 呼吸系统疾病
  • 神经病学
  • 代谢紊乱
  • 感染疾病
  • 其他的

8. 小分子创新 CDMO 市场：区域估计和趋势分析（按产品、药物类型和应用）

  • 市场仪表板：按地区
  • 全球市场概况：按地区
  • 市场规模预测及趋势分析（2021-2033）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争态势

  • 公司分类
  • 小分子创新者 CDMO 市占率分析（2024 年）
  • 公司简介
    • Piramal Pharma Solutions
    • CordenPharma International
    • Wuxi AppTec
    • Cambrex Corporation
    • Recipharm AB
    • Thermo Fisher Scientific, Inc.
    • Lonza
    • Catalent Inc.
    • Siegfried Holding AG
    • Boehringer Ingelheim
    • Labcorp
Product Code: GVR-4-68039-908-0

Small Molecule Innovator CDMO Market Summary

The global small molecule innovator CDMO market size was estimated at USD 41.39 billion in 2024 and is projected to reach USD 69.38 billion by 2033, growing at a CAGR of 6.07% from 2025 to 2033. The growth of the market is due to the increasing outsourcing of drug development and manufacturing by pharmaceutical innovators, particularly in the small molecule space.

As drug pipelines become more complex and regulatory scrutiny tightens, pharmaceutical companies are relying more on CDMOs to provide specialized services such as API synthesis, formulation development, and clinical-scale production. The market is driven by a growing reliance on outsourcing among pharmaceutical companies aiming to streamline operations, reduce internal manufacturing burdens, and accelerate drug development timelines. Innovator companies, especially emerging biotechs with limited infrastructure, increasingly turn to CDMOs for specialized services ranging from early-phase development to commercial manufacturing. This trend is reinforced by the complexity of regulatory compliance, the need for advanced containment facilities for potent APIs, and the high costs associated with maintaining in-house capabilities. The rise in clinical trials and new molecular entities (NMEs) targeting oncology, infectious diseases, and rare disorders is pushing demand for CDMOs that offer high-quality API production, analytical testing, and formulation development expertise under cGMP conditions.

Global Small Molecule Innovator CDMO Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global small molecule innovator CDMO market report based on product, stage type, customer type, therapeutic area, and region.

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Small Molecule API
  • Small Molecule Drug Product
    • Oral Solid Dose
    • Semi-Solid Dose
    • Liquid Dose
    • Others
  • Stage Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Preclinical
  • Clinical
    • Phase I
    • Small
    • Medium
    • Large
    • Phase II
    • Small
    • Medium
    • Large
    • Phase III
    • Small
    • Medium
    • Large
  • Commercial
  • Customer Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical
    • Small
    • Medium
    • Large
  • Biotechnology
  • Therapeutic Area Outlook (Revenue, USD Million, 2021 - 2033)
  • Cardiovascular Diseases
  • Oncology
  • Respiratory Disorders
  • Neurology
  • Metabolic Disorders
  • Infectious Diseases
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Norway
    • Sweden
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Value chain based analysis (Model 2)
    • 1.7.3. Multivariate Analysis (Model 3)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Small Molecule Innovator CDMO Market: Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Small Molecule Innovator CDMO Market Dynamics
    • 3.2.1. Market Driver Impact Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Technological Landscape
  • 3.4. Pricing Model Analysis
  • 3.5. Small Molecule Innovator CDMO Market: Analysis Tools
    • 3.5.1. Porter's Five Forces Analysis
    • 3.5.2. PESTEL Analysis

Chapter 4. Small Molecule Innovator CDMO Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Small Molecule Innovator CDMO Market Product Movement Analysis
  • 4.3. Global Small Molecule Innovator CDMO Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Small Molecule API
    • 4.4.1. Small Molecule API Market Estimates and Forecasts, 2021 - 2033 (USD million)
  • 4.5. Small Molecule Drug Product
    • 4.5.1. Small Molecule Drug Product Market Estimates and Forecasts, 2021 - 2033 (USD million)
    • 4.5.2. Oral Solid Dose
      • 4.5.2.1. Oral Solid Dose Market Estimates and Forecasts, 2021 - 2033 (USD million)
    • 4.5.3. Semi-Solid Dose
      • 4.5.3.1. Semi-Solid Dose Market Estimates and Forecasts, 2021 - 2033 (USD million)
    • 4.5.4. Liquid Dose
      • 4.5.4.1. Liquid Dose Market Estimates and Forecasts, 2021 - 2033 (USD million)
    • 4.5.5. Others
      • 4.5.5.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD million)

Chapter 5. Small Molecule Innovator CDMO Market: Stage Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Small Molecule Innovator CDMO Market Stage Type Movement Analysis
  • 5.3. Global Small Molecule Innovator CDMO Market Size & Trend Analysis, by Stage Type, 2021 to 2033 (USD Million)
  • 5.4. Preclinical
    • 5.4.1. Preclinical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Clinical
    • 5.5.1. Clinical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.2. Phase I
      • 5.5.2.1. Phase I Market Estimates and Forecasts, 2021 - 2033 (USD million)
      • 5.5.2.2. Small
        • 5.5.2.2.1. Small Market Estimates and Forecasts, 2021 - 2033 (USD million)
      • 5.5.2.3. Medium
        • 5.5.2.3.1. Medium Market Estimates and Forecasts, 2021 - 2033 (USD million)
      • 5.5.2.4. Large
        • 5.5.2.4.1. Large Market Estimates and Forecasts, 2021 - 2033 (USD million)
    • 5.5.3. Phase II
      • 5.5.3.1. Phase II Market Estimates and Forecasts, 2021 - 2033 (USD million)
      • 5.5.3.2. Small
        • 5.5.3.2.1. Small Market Estimates and Forecasts, 2021 - 2033 (USD million)
      • 5.5.3.3. Medium
        • 5.5.3.3.1. Medium Market Estimates and Forecasts, 2021 - 2033 (USD million)
      • 5.5.3.4. Large
        • 5.5.3.4.1. Large Market Estimates and Forecasts, 2021 - 2033 (USD million)
    • 5.5.4. Phase III
      • 5.5.4.1. Phase III Market Estimates and Forecasts, 2021 - 2033 (USD million)
      • 5.5.4.2. Small
        • 5.5.4.2.1. Small Market Estimates and Forecasts, 2021 - 2033 (USD million)
      • 5.5.4.3. Medium
        • 5.5.4.3.1. Medium Market Estimates and Forecasts, 2021 - 2033 (USD million)
      • 5.5.4.4. Large
        • 5.5.4.4.1. Large Market Estimates and Forecasts, 2021 - 2033 (USD million)
  • 5.6. Commercial
    • 5.6.1. Commercial Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Small Molecule Innovator CDMO Market: Customer Type Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Small Molecule Innovator CDMO Market Customer Type Movement Analysis
  • 6.3. Global Small Molecule Innovator CDMO Market Size & Trend Analysis, by Customer Type, 2021 to 2033 (USD Million)
  • 6.4. Pharmaceutical
    • 6.4.1. Pharmaceutical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.2. Small
      • 6.4.2.1. Small Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Medium
      • 6.4.3.1. Medium Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.4. Large
      • 6.4.4.1. Large Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Biotechnology
    • 6.5.1. Biotechnology Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Small Molecule Innovator CDMO Market: Therapeutic Area Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Small Molecule Innovator CDMO Market Therapeutic Area Movement Analysis
  • 7.3. Global Small Molecule Innovator CDMO Market Size & Trend Analysis, by Therapeutic Area, 2021 to 2033 (USD Million)
  • 7.4. Cardiovascular diseases
    • 7.4.1. Cardiovascular diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Oncology
    • 7.5.1. Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Respiratory disorders
    • 7.6.1. Respiratory disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Neurology
    • 7.7.1. Neurology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. Metabolic Disorders
    • 7.8.1. Metabolic Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.9. Infectious Diseases
    • 7.9.1. Infectious Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.10. Others
    • 7.10.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Small Molecule Innovator CDMO Market: Regional Estimates & Trend Analysis by Product, Drug Type, Application

  • 8.1. Regional Market Dashboard
  • 8.2. Global Regional Market Snapshot
  • 8.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 8.4. North America
    • 8.4.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Europe
    • 8.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.7. Denmark
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.8. Sweden
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Competitive Scenario
      • 8.5.8.3. Regulatory Framework
      • 8.5.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.9. Norway
      • 8.5.9.1. Key Country Dynamics
      • 8.5.9.2. Competitive Scenario
      • 8.5.9.3. Regulatory Framework
      • 8.5.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competitive Scenario
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.5. Australia
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Competitive Scenario
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.6. South Korea
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Competitive Scenario
      • 8.6.6.3. Regulatory Framework
      • 8.6.6.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.7. Thailand
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Competitive Scenario
      • 8.6.7.3. Regulatory Framework
      • 8.6.7.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.8. MEA
    • 8.8.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Competitive Scenario
      • 8.8.2.3. Regulatory Framework
      • 8.8.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Competitive Scenario
      • 8.8.3.3. Regulatory Framework
      • 8.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Competitive Scenario
      • 8.8.4.3. Regulatory Framework
      • 8.8.4.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Competitive Scenario
      • 8.8.5.3. Regulatory Framework
      • 8.8.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Small Molecule Innovator CDMO Market Share Analysis, 2024
  • 9.3. Company Profiles
    • 9.3.1. Piramal Pharma Solutions
      • 9.3.1.1. Company overview
      • 9.3.1.2. Financial performance
      • 9.3.1.3. Product benchmarking
      • 9.3.1.4. Strategic initiatives
    • 9.3.2. CordenPharma International
      • 9.3.2.1. Company overview
      • 9.3.2.2. Financial performance
      • 9.3.2.3. Product benchmarking
      • 9.3.2.4. Strategic initiatives
    • 9.3.3. Wuxi AppTec
      • 9.3.3.1. Company overview
      • 9.3.3.2. Financial performance
      • 9.3.3.3. Product benchmarking
      • 9.3.3.4. Strategic initiatives
    • 9.3.4. Cambrex Corporation
      • 9.3.4.1. Company overview
      • 9.3.4.2. Financial performance
      • 9.3.4.3. Product benchmarking
      • 9.3.4.4. Strategic initiatives
    • 9.3.5. Recipharm AB
      • 9.3.5.1. Company overview
      • 9.3.5.2. Financial performance
      • 9.3.5.3. Product benchmarking
      • 9.3.5.4. Strategic initiatives
    • 9.3.6. Thermo Fisher Scientific, Inc.
      • 9.3.6.1. Company overview
      • 9.3.6.2. Financial performance
      • 9.3.6.3. Product benchmarking
      • 9.3.6.4. Strategic initiatives
    • 9.3.7. Lonza
      • 9.3.7.1. Company overview
      • 9.3.7.2. Financial performance
      • 9.3.7.3. Product benchmarking
      • 9.3.7.4. Strategic initiatives
    • 9.3.8. Catalent Inc.
      • 9.3.8.1. Company overview
      • 9.3.8.2. Financial performance
      • 9.3.8.3. Product benchmarking
      • 9.3.8.4. Strategic initiatives
    • 9.3.9. Siegfried Holding AG
      • 9.3.9.1. Company overview
      • 9.3.9.2. Financial performance
      • 9.3.9.3. Product benchmarking
      • 9.3.9.4. Strategic initiatives
    • 9.3.10. Boehringer Ingelheim
      • 9.3.10.1. Company overview
      • 9.3.10.2. Financial performance
      • 9.3.10.3. Product benchmarking
      • 9.3.10.4. Strategic initiatives
    • 9.3.11. Labcorp
      • 9.3.11.1. Company overview
      • 9.3.11.2. Financial performance
      • 9.3.11.3. Product benchmarking
      • 9.3.11.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America Small Molecule Innovator CDMO market, by region, 2021 - 2033 (USD Million)
  • Table 3 North America Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 4 North America Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 5 North America Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 6 North America Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 7 U.S. Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 8 U.S. Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 9 U.S. Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 10 U.S. Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 11 Canada Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 12 Canada Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 13 Canada Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 14 Canada Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 15 Mexico Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 16 Mexico Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 17 Mexico Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 18 Mexico Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 19 Europe Small Molecule Innovator CDMO market, by region, 2021 - 2033 (USD Million)
  • Table 20 Europe Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 21 Europe Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 22 Europe Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 23 Europe Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 24 Germany Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 25 Germany Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 26 Germany Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 27 Germany Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 28 UK Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 29 UK Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 30 UK Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 31 UK Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 32 France Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 33 France Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 34 France Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 35 France Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 36 Italy Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 37 Italy Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 38 Italy Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 39 Italy Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 40 Spain Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 41 Spain Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 42 Spain Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 43 Spain Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 44 Denmark Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 45 Denmark Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 46 Denmark Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 47 Denmark Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 48 Sweden Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 49 Sweden Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 50 Sweden Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 51 Sweden Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 52 Norway Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 53 Norway Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 54 Norway Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 55 Norway Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 56 Asia Pacific Small Molecule Innovator CDMO market, by region, 2021 - 2033 (USD Million)
  • Table 57 Asia Pacific Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 58 Asia Pacific Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 59 Asia Pacific Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 60 Asia Pacific Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 61 China Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 62 China Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 63 China Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 64 China Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 65 Japan Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 66 Japan Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 67 Japan Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 68 Japan Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 69 India Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 70 India Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 71 India Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 72 India Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 73 South Korea Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 74 South Korea Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 75 South Korea Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 76 South Korea Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 77 Australia Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 78 Australia Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 79 Australia Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 80 Australia Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 81 Thailand Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 82 Thailand Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 83 Thailand Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 84 Thailand Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 85 Latin America Small Molecule Innovator CDMO market, by region, 2021 - 2033 (USD Million)
  • Table 86 Latin America Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 87 Latin America Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 88 Latin America Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 89 Latin America Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 90 Brazil Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 91 Brazil Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 92 Brazil Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 93 Brazil Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 94 Argentina Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 95 Argentina Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 96 Argentina Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 97 Argentina Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 98 MEA Small Molecule Innovator CDMO market, by region, 2021 - 2033 (USD Million)
  • Table 99 MEA Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 100 MEA Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 101 MEA Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 102 MEA Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 103 South Africa Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 104 South Africa Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 105 South Africa Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 106 South Africa Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 107 Saudi Arabia Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 108 Saudi Arabia Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 109 Saudi Arabia Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 110 Saudi Arabia Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 111 UAE Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 112 UAE Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 113 UAE Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 114 UAE Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 115 Kuwait Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 116 Kuwait Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 117 Kuwait Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 118 Kuwait Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Small Molecule Innovator CDMO market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Commodity flow analysis
  • Fig. 8 Value-Chain-Based Sizing & Forecasting
  • Fig. 9 QFD model sizing & forecasting
  • Fig. 10 Bottom-up approach
  • Fig. 11 Market snapshot
  • Fig. 12 Segment snapshot
  • Fig. 13 Segment snapshot
  • Fig. 14 Segment snapshot
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Parent market outlook, 2024 (USD Million)
  • Fig. 17 Ancillary market outlook, 2024 (USD Million)
  • Fig. 18 Small Molecule Innovator CDMO market dynamics
  • Fig. 19 Porter's five forces analysis
  • Fig. 20 PESTEL analysis
  • Fig. 21 Small Molecule Innovator CDMO market Product outlook: Segment dashboard
  • Fig. 22 Small Molecule Innovator CDMO market, by Product segment: Market share, 2024 & 2033
  • Fig. 23 Small Molecule API market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Small Molecule Drug Product market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Oral Solid Dose market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Semi-Solid Dose market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Liquid Dose market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Small Molecule Innovator CDMO market Stage Type outlook: Segment dashboard
  • Fig. 30 Small Molecule Innovator CDMO market, by Stage Type segment: Market share, 2024 & 2033
  • Fig. 31 Preclinical market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Clinical market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Phase I market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Small phase I market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Medium phase I market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Large phase I market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Phase II market estimates and forecasts, 2021 - 2033 (USD Million
  • Fig. 38 Small phase II market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Medium phase II market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Large phase II market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Phase III market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Small phase III market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Medium phase III market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Large phase III market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Small Molecule Innovator CDMO market Customer Type outlook: Segment dashboard
  • Fig. 46 Small Molecule Innovator CDMO market, by Customer Type segment: Market share, 2024 & 2033
  • Fig. 47 Pharmaceutical market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Small pharmaceutical companies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Medium pharmaceutical companies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Large pharmaceutical companies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Biotechnology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Small Molecule Innovator CDMO market Therapeutic Area outlook: Segment dashboard
  • Fig. 53 Small Molecule Innovator CDMO market, by Therapeutic Area segment: Market share, 2024 & 2033
  • Fig. 54 Cardiovascular diseases market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Oncology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Respiratory disorders market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Neurology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Metabolic Disorders market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Infectious Diseases market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Regional market: Key takeaways
  • Fig. 62 Regional marketplace: Key takeaways
  • Fig. 63 North America Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 U S Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 Canada Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Mexico Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Europe Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 UK Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 Germany Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 France Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 Italy Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Spain Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Denmark Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 Norway Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Sweden Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 87 Asia Pacific Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 Japan Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 China Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 India Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 Australia Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 96 Key country dynamics
  • Fig. 97 South Korea Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 98 Key country dynamics
  • Fig. 99 Thailand Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 100 Latin America Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 101 Key country dynamics
  • Fig. 102 Brazil Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 103 Key country dynamics
  • Fig. 104 Argentina Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 105 MEA Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 106 Key country dynamics
  • Fig. 107 South Africa Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 108 Key country dynamics
  • Fig. 109 Saudi Arabia Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 110 Key country dynamics
  • Fig. 111 Kuwait Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 112 Key country dynamics
  • Fig. 113 UAE Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 114 Market participant categorization
  • Fig. 115 Heat map analysis